The antioxidative-enzyme-encoding genes paraoxonase 1 (PON1), glutathione-S-transferases (GSTs), and catalase (CAT) stood out in a retrospective series of 101 patients with HER2-positive breast cancer that received adjuvant trastuzumab [40]. This evidence concerns the gene CAT and breast carcinoma.